Market Overview:
The global DNA sequencing instruments market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for DNA sequencing for various applications such as molecular biology, evolutionary biology, metagenomics, and medicine. In addition, the increasing focus on precision medicine is also contributing to the growth of this market. North America dominates the global DNA sequencing instruments market followed by Europe and Asia Pacific.
Product Definition:
DNA sequencing instruments are used to determine the order of nucleotides in a DNA molecule. This information is used to study genetic disorders and to develop new treatments for diseases.
Emulsion PCR:
PCR-based method for the detection of genetic abnormalities is termed as Emulsion PCR (E-PCR). It is a new approach in molecular diagnostics which has overcome the limitations of traditional PCR. Traditional Polymerase Chain Reaction (PCR) technology requires DNA to be fragmented into small pieces, before it can be amplified.
Bridge Amplification:
The process of amplifying the signal from a weak signal region is called bridge amplification. It is used in DNA sequencing instruments to improve the sensitivity and accuracy of sequence analysis. The technique helps detect low-frequency variations in DNA sequences, which are not easily detected by eye or ear.
In a conventional sequencing instrument, when there is little or no input signal from the sample, then it may cause problems during data collection.
Application Insights:
Molecular biology accounted for the largest revenue share in 2016 and is anticipated to continue leading over the forecast period. This is due to rising demand for DNA sequencing instruments by research institutes, hospitals, and diagnostic laboratories. Furthermore, an increase in research activities pertaining to human health has fueled product demand.
The evolutionary biology segment is expected to register a significant CAGR during the forecast period owing to increasing interest among researchers studying various aspects of evolution such as population genetics, genealogy & pedigrees, fossil records & timelines etc. The metagenomics segment also holds considerable market potential owing to its growing adoption across diverse applications such as food safety & security (quality control), environmental monitoring including oceanic plankton and soil bacteria etc., medical diagnostics (personalized medicine) etc. Other applications include plant breeding and crop improvement along with animal breeding which includes petrology mineralogy ornithology entomology ethology etcetera).
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a substantial number of research institutes and universities that are engaged in sequencing-based studies. Moreover, these instruments are used for various applications such as disease diagnosis, drug discovery, genetic identification and monitoring environmental conditions. The U.S.-based companies hold a significant share in this industry due to their continuous R&D activities related to next-generation sequencing technologies.
Asia Pacific is expected to grow at an exponential rate over the forecast period owing to increasing investments by governments and private organizations for DNA analysis tools development along with rising awareness about personalized medicine among people living in this region. Japan has been observed as one of the most innovative countries across all major industries including healthcare since last few decades; hence it holds a prominent position among other Asian countries pertaining its high per capita income level compared with others from Asia Pacific region ( ).
Growth Factors:
- Increasing demand for personalized medicine
- Rising prevalence of cancer and other genetic disorders
- Technological advancements in DNA sequencing instruments
- Growing number of research institutes and laboratories worldwide
- Increasing funding for DNA sequencing research
Scope Of The Report
Report Attributes
Report Details
Report Title
DNA Sequencing Instruments Market Research Report
By Type
Emulsion PCR, Bridge Amplification, Single-molecule
By Application
Molecular Biology, Evolutionary Biology, Metagenomics, Medicine, Other
By Companies
Roche, Johnson & Johnson, Illumina, Life Technologies, Beckman Coulter, Pacific Biosciences, Oxford Nanopore, GE Healthcare Life Sciences, Abbott Laboratories
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global DNA Sequencing Instruments Market Report Segments:
The global DNA Sequencing Instruments market is segmented on the basis of:
Types
Emulsion PCR, Bridge Amplification, Single-molecule
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Molecular Biology, Evolutionary Biology, Metagenomics, Medicine, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- Johnson & Johnson
- Illumina
- Life Technologies
- Beckman Coulter
- Pacific Biosciences
- Oxford Nanopore
- GE Healthcare Life Sciences
- Abbott Laboratories
Highlights of The DNA Sequencing Instruments Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Emulsion PCR
- Bridge Amplification
- Single-molecule
- By Application:
- Molecular Biology
- Evolutionary Biology
- Metagenomics
- Medicine
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the DNA Sequencing Instruments Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
DNA sequencing instruments are machines that can read the sequence of DNA bases in a sample.
Some of the major companies in the dna sequencing instruments market are Roche, Johnson & Johnson, Illumina, Life Technologies, Beckman Coulter, Pacific Biosciences, Oxford Nanopore, GE Healthcare Life Sciences, Abbott Laboratories.
The dna sequencing instruments market is expected to grow at a compound annual growth rate of 10.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. DNA Sequencing Instruments Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. DNA Sequencing Instruments Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. DNA Sequencing Instruments Market - Supply Chain
4.5. Global DNA Sequencing Instruments Market Forecast
4.5.1. DNA Sequencing Instruments Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. DNA Sequencing Instruments Market Size (000 Units) and Y-o-Y Growth
4.5.3. DNA Sequencing Instruments Market Absolute $ Opportunity
5. Global DNA Sequencing Instruments Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. DNA Sequencing Instruments Market Size and Volume Forecast by Type
5.3.1. Emulsion PCR
5.3.2. Bridge Amplification
5.3.3. Single-molecule
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global DNA Sequencing Instruments Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. DNA Sequencing Instruments Market Size and Volume Forecast by Application
6.3.1. Molecular Biology
6.3.2. Evolutionary Biology
6.3.3. Metagenomics
6.3.4. Medicine
6.3.5. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global DNA Sequencing Instruments Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. DNA Sequencing Instruments Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global DNA Sequencing Instruments Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. DNA Sequencing Instruments Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global DNA Sequencing Instruments Demand Share Forecast, 2019-2026
9. North America DNA Sequencing Instruments Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America DNA Sequencing Instruments Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America DNA Sequencing Instruments Market Size and Volume Forecast by Application
9.4.1. Molecular Biology
9.4.2. Evolutionary Biology
9.4.3. Metagenomics
9.4.4. Medicine
9.4.5. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America DNA Sequencing Instruments Market Size and Volume Forecast by Type
9.7.1. Emulsion PCR
9.7.2. Bridge Amplification
9.7.3. Single-molecule
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America DNA Sequencing Instruments Demand Share Forecast, 2019-2026
10. Latin America DNA Sequencing Instruments Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America DNA Sequencing Instruments Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America DNA Sequencing Instruments Market Size and Volume Forecast by Application
10.4.1. Molecular Biology
10.4.2. Evolutionary Biology
10.4.3. Metagenomics
10.4.4. Medicine
10.4.5. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America DNA Sequencing Instruments Market Size and Volume Forecast by Type
10.7.1. Emulsion PCR
10.7.2. Bridge Amplification
10.7.3. Single-molecule
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America DNA Sequencing Instruments Demand Share Forecast, 2019-2026
11. Europe DNA Sequencing Instruments Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe DNA Sequencing Instruments Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe DNA Sequencing Instruments Market Size and Volume Forecast by Application
11.4.1. Molecular Biology
11.4.2. Evolutionary Biology
11.4.3. Metagenomics
11.4.4. Medicine
11.4.5. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe DNA Sequencing Instruments Market Size and Volume Forecast by Type
11.7.1. Emulsion PCR
11.7.2. Bridge Amplification
11.7.3. Single-molecule
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe DNA Sequencing Instruments Demand Share, 2019-2026
12. Asia Pacific DNA Sequencing Instruments Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific DNA Sequencing Instruments Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific DNA Sequencing Instruments Market Size and Volume Forecast by Application
12.4.1. Molecular Biology
12.4.2. Evolutionary Biology
12.4.3. Metagenomics
12.4.4. Medicine
12.4.5. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific DNA Sequencing Instruments Market Size and Volume Forecast by Type
12.7.1. Emulsion PCR
12.7.2. Bridge Amplification
12.7.3. Single-molecule
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific DNA Sequencing Instruments Demand Share, 2019-2026
13. Middle East & Africa DNA Sequencing Instruments Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa DNA Sequencing Instruments Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa DNA Sequencing Instruments Market Size and Volume Forecast by Application
13.4.1. Molecular Biology
13.4.2. Evolutionary Biology
13.4.3. Metagenomics
13.4.4. Medicine
13.4.5. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa DNA Sequencing Instruments Market Size and Volume Forecast by Type
13.7.1. Emulsion PCR
13.7.2. Bridge Amplification
13.7.3. Single-molecule
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa DNA Sequencing Instruments Demand Share, 2019-2026
14. Competition Landscape
14.1. Global DNA Sequencing Instruments Market: Market Share Analysis
14.2. DNA Sequencing Instruments Distributors and Customers
14.3. DNA Sequencing Instruments Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Roche
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Johnson & Johnson
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Illumina
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Life Technologies
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Beckman Coulter
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Pacific Biosciences
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Oxford Nanopore
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. GE Healthcare Life Sciences
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Abbott Laboratories
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
